moderna

American Biotechnology firm, Moderna (NASDAQ: MRNA) shares closed more than 12% higher on Monday after the company said it believes its COVID-19 vaccine protects against new variants found in Britain and South Africa. The company will publish data from its tests against the South African and UK...

American Biotechnology firm, Moderna (NASDAQ: MRNA) shares closed in positive for the second consecutive day. The $MRNA stock closed more than 6% higher on Wednesday after the early data of its experimental COVID-19 vaccine showed comparable immune response between older and younger volunteers...